20/06/2024 Healthcare
Clavsat 1.2, an Amoxicillin Potassium Clavulanate Injection, combines the antibiotic properties of amoxicillin with the beta-lactamase inhibitor clavulanate. This formulation is effective against a broad spectrum of bacterial infections, including those resistant to amoxicillin alone. Administered intravenously, Clavsat 1.2 ensures rapid absorption and distribution in treating severe infections. It is a critical tool in combating bacterial resistance and providing reliable therapy in hospital settings where intravenous administration is necessary.Available in PCD Franchise for injectable range and third party manufacturing.
CLAVSAT-375 tablets combine Amoxicillin and Potassium Clavulanate, offering a potent antibiotic therapy. Amoxicillin, a penicillin derivative, inhibit...
Amoxicillin & Potassium Clavulanate Oral Suspension IP, branded as Clavsat DRY SYRUP, is a combination antibiotic used to treat various bacterial ...
"CLAVSAT-625 tablets combine Amoxicillin and Potassium Clavulanate to treat bacterial infections effectively. Amoxicillin, a penicillin antibiotic, in...
Cefisat-CV Dry Syrup, containing Cefixime and Potassium Clavulanate for Oral Suspension, is a powerful antibiotic combination used to treat various ba...
More Details